Incidence, characterization and clinical implications of sleep disorders in patients with atrial flutter

N. Grau, V. Bazan, M. Felez, C. Sanjuas, J. Marti-Almor, J. Gea (Barcelona, Spain)

Source: Annual Congress 2011 - Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities
Session: Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities
Session type: Thematic Poster Session
Number: 2256
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Grau, V. Bazan, M. Felez, C. Sanjuas, J. Marti-Almor, J. Gea (Barcelona, Spain). Incidence, characterization and clinical implications of sleep disorders in patients with atrial flutter. Eur Respir J 2011; 38: Suppl. 55, 2256

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prevalence and clinical predictors of sleep apnea in patients with paroxysmal atrial fibrillation
Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases
Year: 2019


Obstructive sleep apnea in patients with typical atrial flutter: Clinical, prognostic and therapeutic implications
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012

Rhythm control decreased severity of sleep-disordered breathing in patients with atrial fibrillation following cardioversion
Source: Annual Congress 2013 –Heart, blood and metabolism in sleep disordered breathing
Year: 2013

Atrial fibrillation in critical care patients with respiratory failure: Incidence and clinical effects
Source: Annual Congress 2012 - Multidisciplinary critical care
Year: 2012

Clinical profile of patients with sleep related breathing disorders and left ventricular dysfunction
Source: Eur Respir J 2001; 18: Suppl. 33, 89s
Year: 2001

Validation of the STOP-BANG questionnaire as a screening tool for sleep apnoea in patients undergoing ablation for paroxysmal atrial fibrillation
Source: Annual Congress 2013 –Ask, see and do: old and new technology in sleep disordered breathing
Year: 2013

STOP-Bang and Berlin questionnaire as predictors of sleep apnea in patients with paroxysmal atrial fibrillation
Source: International Congress 2019 – Screening tools, prevalence and predictors of obstructive sleep apnoea
Year: 2019


Risk factors for the development of malignant arrhythmias in patients with obstructive sleep apnea and systolic ventricular dysfunction
Source: International Congress 2019 – Challenging issues in the clinical aspects of sleep-disordered breathing
Year: 2019




Risk factors for non-compliance with continuous positive airway pressure therapy in patients with obstructive sleep apnea and paroxysmal atrial fibrillation
Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Year: 2020


Prevalence of atrial fibrillation (AF) in obstructive sleep apnea patients (OSA). Preliminary results
Source: Eur Respir J 2007; 30: Suppl. 51, 331s
Year: 2007

Is obstructive sleep apnoea related to incident atrial fibrillation?
Source: ISSN=ISSN 1810-6838, ISBN=, page=379
Year: 2007

Occurance of sleep disordered breathing in patients with atrial fibrillation
Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea
Year: 2009

Predictors of recurrence in patients undergoing cryoballoon ablation for treatment of atrial fibrillation: The independent role of sleep disordered breathing
Source: Annual Congress 2011 - Physiology and cardiometabolic comorbidities in obstructive sleep apnoea
Year: 2011

Improving anticoagulation practice in respiratory patients with non-valvular atrial fibrillation
Source: International Congress 2016 – The best clinical approach to lung diseases
Year: 2016


Risk factors for asymptomatic atrial fibrillation in patients with COPD
Source: International Congress 2018 – Cardiovascular morbidities in COPD
Year: 2018


Atrial flutter and fibrillation in patients with chronic pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012


Inflammatory pathways in patients with chronic obstructive pulmonary disease and paroxysmal atrial fibrillation
Source: Eur Respir J 2007; 30: Suppl. 51, 707s
Year: 2007

Risk factors for new-onset atrial fibrillation in patients with asthma-COPD overlap syndrome (ACOS)
Source: International Congress 2019 – Insights into physiological diagnostic services
Year: 2019


Increased risk of atrial fibrillation in patients with acute exacerbation of chronic obstructive pulmonary disease and sinus rhythm
Source: International Congress 2018 – Cardiovascular morbidities in COPD
Year: 2018

Effect of continuous positive airway pressure in patients with paroxysmal atrial fibrillation and obstructive sleep apnea
Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Year: 2020